학술논문

A randomized study of the safety and pharmacokinetics of GSK3358699, a mononuclear myeloid-targeted bromodomain and extra-terminal domain inhibitor
Document Type
Article
Source
In: British Journal of Clinical Pharmacology. (British Journal of Clinical Pharmacology, May 2022, 88(5):2140-2155)
Subject
Language
English
ISSN
13652125
03065251